Columnist Juliet Taylor and her late husband, Jeff, fought hard for precious holiday moments after he was diagnosed with ALS.

ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

While briefly changing roles with her husband, columnist Kristin Neva got a glimpse of how frustrating it is to have difficulty speaking.

Neurosense Therapeutics said it will seek conditional approval of PrimeC as an ALS treatment in Canada in mid-2006.

Using adaptive tools and following ALS kitchen safety strategies can make cooking and eating safer when living with ALS.

Slowing down in a fast-paced world while living with ALS isn’t surrendering, writes columnist. It’s an active choice to be ...

Actor Eric Dane is joining nonprofit Target ALS on a campaign aiming to raise $500,000 for ALS research by Dec. 31.

The ALS Association awarded a $1 million grant to support a clinical trial testing Pasithea's MEK inhibitor PAS-004 in people ...

Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.

Amyotrophic lateral sclerosis (ALS) is more common in some parts of the U.S. than others, and it has a… ...